Search

Your search keyword '"Golanov, Andrey"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Golanov, Andrey" Remove constraint Author: "Golanov, Andrey"
327 results on '"Golanov, Andrey"'

Search Results

1. Negligible effect of brain MRI data preprocessing for tumor segmentation

3. Systematic Clinical Evaluation of A Deep Learning Method for Medical Image Segmentation: Radiosurgery Application

4. Medulloblastomas in Pediatric and Adults

5. Subgroup and subtype-specific outcomes in adult medulloblastoma.

6. Universal Loss Reweighting to Balance Lesion Size Inequality in 3D Medical Image Segmentation

7. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.

8. Multi-domain CT Metal Artifacts Reduction Using Partial Convolution Based Inpainting

9. Deep Learning for Brain Tumor Segmentation in Radiosurgery: Prospective Clinical Evaluation

10. Brain Tumor Image Retrieval via Multitask Learning

11. Tumor Delineation For Brain Radiosurgery by a ConvNet and Non-Uniform Patch Generation

12. Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis

13. Deep Learning for Brain Tumor Segmentation in Radiosurgery: Prospective Clinical Evaluation

15. Pilocytic Astrocytomas

16. Craniopharyngiomas

21. Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker

22. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation

23. Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B

26. Molecular progression of SHH-activated medulloblastomas

27. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles

30. Table S6 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study

31. Figure S7 from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study

32. Supplementary Legend from Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study

34. H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers

35. European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH)

37. Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity

39. Reparative properties of human glioblastoma cells after single exposure to a wide range of X-ray doses

41. PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study

47. Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study

49. Additional file 2 of Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation

50. Additional file 1 of Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation

Catalog

Books, media, physical & digital resources